Stories Tagged as
Astrazeneca
Evusheld offers vulnerable Americans protection from COVID. But getting it has been complicated.
by
Lily Jamali
May 24, 2022
Scarcity and a lack of outreach has left millions of immunocompromised Americans without access to the treatment.
Simmering tensions over EU vaccine distribution threaten to boil over
Jan 27, 2021
The 27-nation bloc is battling with manufacturers over its spot in the priority list for receiving COVID vaccines.
The cost of "vaccine nationalism": $9 trillion
Jan 26, 2021
With shortfalls in vaccine supplies, countries across the world are concerned about getting their fair share of doses.
AstraZeneca vaccine is third to show promising data in unprecedented hurry-up race
by
Scott Tong
Nov 23, 2020
The COVID-19 vaccine is being produced so quickly due to a combination of factors involving the research community, government, industry and the public.